Volkswagen said on Wednesday it sold a 2.2% stake in Traton for 360 million euros ($393 million) or 32.75 euros per share for better trading in shares of the commercial-vehicles subsidiary.

The mRNA technology was used to rapidly develop and deploy two effective vaccines that offered protection against the Covid-19 pandemic.